Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-01

Clinical Trial Update: Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates that an autologous adipose-derived stem/stromal cell therapy for inflammatory bowel diseases is currently suspended, with Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous adipose-derived stem/stromal cells (adipose-derived stem/stromal cells)

Snippet

Sponsor: Healeon Medical Inc | Conditions: Inflammatory Bowel Diseases | Phase 1, Phase 2 | Status: SUSPENDED